Pre-close · Specialty Chemicals

Independent Sponsor IP Transfer & Licensing in Specialty Chemicals

Securities and M&A counsel for independent sponsors structuring specialty chemicals transactions, from LOI to close to the capital markets that open up afterward.

EV range $15M to $200M EV EBITDA $3M to $28M Audience Buy-side / Sponsor
The deal context

The economics on a specialty chemicals platform deal usually hinge on a handful of structural decisions. IP Transfer & Licensing is one of them.

The typical specialty chemicals platform sits at $15M to $200M EV with EBITDA in the $3M to $28M range. The thesis runs on niche formulator or contract manufacturing buy-up. The IP lives in the formulator's head as often as in the company. Structure for that risk explicitly.

The moves

How IP Transfer & Licensing actually gets structured.

  1. Identify all IP, including informal employee-inventor work product.

  2. Pull assignments and works-for-hire records, with gaps remediated pre-close.

  3. Address open-source license compliance in any software stack.

  4. Plan trademark assignment recordation and continuation filings.

  5. In specialty chemicals, layer in chemical inventory transfer filed as part of the IP Transfer & Licensing workstream.

The common mistake

Assuming the company owns its IP because the website says so. Without paper, ownership is a hope.

Jason's take
"Every piece of IP in the deal needs a chain of title. Find the gaps before the buyer's counsel does."
Jason Powell · IP Transfer & Licensing
Capital after close

The deal is one thing. The capital that opens up after close is another.

Most independent sponsors solve the closing capital and then run into the post-close capital problem alone. The capital markets relationships that matter at month 18 are part of this practice.

MONTH 18
Senior refi
MONTH 24
Dividend recap
MONTH 36
Growth equity
YEAR 4–5
Strategic exit
TALK TO JASON

An LOI on the desk, a specialty chemicals target, and a IP Transfer & Licensing question worth a real conversation.

Twenty minutes of practitioner-grade input from a securities attorney whose first move is to read the deal, not the engagement letter.